Ernexa Therapeutics ERNA
NASDAQ ERNA
$4.86 +0.25 (+5.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Ernexa Therapeutics Inc. (ERNA) Accumulated Expenses (2010 - 2026)

Ernexa Therapeutics' (ERNA) quarterly Accumulated Expenses came in at $497000.0 in Q1 2026, up 4041.67% YoY from $12000.0 in Q1 2025, and down 44.65% on a QoQ basis from $898000.0 in Q4 2025.

Ernexa Therapeutics Inc. (ERNA) Accumulated Expenses (2010 - 2026) Analysis & Trends

Ernexa Therapeutics (ERNA) has 17 years of Accumulated Expenses data on file, last reported at $497000.0 in Q1 2026.

  • Quarterly Accumulated Expenses rose 4041.67% year-over-year to $497000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $497000.0 (up 4041.67% YoY) and the FY2025 annual result came in at $898000.0, up 7383.33% from the prior year.
  • Accumulated Expenses fell to $497000.0 in Q1 2026, from $898000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $5.0 million in Q3 2023 to a low of $12000.0 in Q4 2024.
  • A 5-year average of $1.4 million and a median of $938000.0 in 2025 frame the typical range for Accumulated Expenses.
  • The widest YoY moves for Accumulated Expenses: up 7383.33% in 2025, down 99.36% in 2025.
  • Tracing ERNA's Accumulated Expenses over 5 years: stood at $1.1 million in 2022, then tumbled by 83.47% to $176000.0 in 2023, then sank by 93.18% to $12000.0 in 2024, then soared by 7383.33% to $898000.0 in 2025, then plunged by 44.65% to $497000.0 in 2026.
  • The last three Accumulated Expenses figures came in at $497000.0 (Q1 2026), $898000.0 (Q4 2025), and $859000.0 (Q3 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Mn
Mar 31, 2026 497,000.00
Dec 31, 2025 898,000.00
Sep 30, 2025 859,000.00
Jun 30, 2025 938,000.00
Mar 31, 2025 12,000.00
Dec 31, 2024 12,000.00
Sep 30, 2024 1.17 Mn
Jun 30, 2024 134,000.00
Mar 31, 2024 1.87 Mn
Dec 31, 2023 176,000.00
Sep 30, 2023 5.02 Mn
Jun 30, 2023 2.11 Mn
Mar 31, 2023 3.63 Mn
Dec 31, 2022 1.07 Mn
Sep 30, 2022 1.70 Mn
Jun 30, 2022 3.82 Mn
Mar 31, 2022 637,000.00
Dec 31, 2021 656,000.00
Sep 30, 2021 589,652.00